BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
5/11/2023 8:05:04 AM | Browse: 125 | Download: 337
 |
Received |
|
2022-11-18 20:58 |
|
Peer-Review Started |
|
2022-11-18 20:59 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2023-02-15 23:28 |
|
Revised |
|
2023-02-27 10:04 |
|
Second Decision |
|
2023-04-10 03:19 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Company Editor-in-Chief |
|
2023-04-10 21:56 |
|
Articles in Press |
|
2023-04-10 21:56 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
2023-04-16 23:59 |
|
Typeset the Manuscript |
|
2023-04-28 03:47 |
|
Publish the Manuscript Online |
|
2023-05-11 08:05 |
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Oncology |
| Manuscript Type |
Retrospective Study |
| Article Title |
Prolonged hyperthermic intraperitoneal chemotherapy duration with 90 minutes cisplatin might increase overall survival in gastric cancer patients with peritoneal metastases
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Heinrich Steinhoff, Miklos Acs, Sebastian Blaj, Magdolna Dank, Magdolna Herold, Zoltan Herold, Jonas Herzberg, Patricia Sanchez-Velazquez, Tim Strate, Attila Marcell Szasz and Pompiliu Piso |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Heinrich Steinhoff, MD, Doctor, Surgeon, Department of General and Visceral Surgery, Hospital Barmherzige Brüder, Prüfeninger Str. 86, Regensburg 93049, Germany. heinrich.steinhoff@barmherzige-regensburg.de |
| Key Words |
Cytoreductive surgery; Hyperthermic intraperitoneal chemotherapy; Peritoneal metastasis; Stomach neoplasms; Gastric cancer |
| Core Tip |
Advanced gastric cancer (GC) cases with peritoneal metastases are known for their poor survival rate. It has been previously reported that these patients highly benefit from cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC) but the available data on this treatment is scarce. In this study, we retrospectively analyzed the clinicopathological and laboratory data of 73 patients with advanced GC and synchronous peritoneal metastases. It was found that prolonged HIPEC duration after macroscopic complete CRS in the scope of multimodal treatment along with advanced perioperative chemotherapy and biologicals may serve as the best currently available therapy for these patients. |
| Publish Date |
2023-05-11 08:05 |
| Citation |
Steinhoff H, Acs M, Blaj S, Dank M, Herold M, Herold Z, Herzberg J, Sanchez-Velazquez P, Strate T, Szasz AM, Piso P. Prolonged hyperthermic intraperitoneal chemotherapy duration with 90 min cisplatin might increase overall survival in gastric cancer patients with peritoneal metastases . World J Gastroenterol 2023; 29(18): 2850-2863 |
| URL |
https://www.wjgnet.com/1007-9327/full/v29/i18/2850.htm |
| DOI |
https://dx.doi.org/10.3748/wjg.v29.i18.2850 |
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
